Literature DB >> 8783725

Emergence of Mycobacterium kansasii as the leading mycobacterial pathogen isolated over a 20-year period at a midwestern Veterans Affairs hospital.

M J Bittner1, E A Horowitz, T J Safranek, L C Preheim.   

Abstract

Entities:  

Mesh：

Year:  1996        PMID： 8783725     DOI： 10.1093/clinids/22.6.1109

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  10 in total

Review 1.  Nontuberculous mycobacteria and the lung: from suspicion to treatment.

Authors:  Emmet E McGrath; Zoe Blades; Josie McCabe; Hannah Jarry; Paul B Anderson
Journal:  Lung       Date:  2010-04-09       Impact factor: 2.584

2.  Clinical features and follow up of 302 patients with Mycobacterium kansasii pulmonary infection: a 50 year experience.

Authors:  N Maliwan; J R Zvetina
Journal:  Postgrad Med J       Date:  2005-08       Impact factor: 2.401

3.  Treatment of Non-Tuberculous Mycobacterial Lung Disease.

Authors:  Julie V Philley; Mary Ann DeGroote; Jennifer R Honda; Michael M Chan; Shannon Kasperbauer; Nicholas D Walter; Edward D Chan
Journal:  Curr Treat Options Infect Dis       Date:  2016-10-11

4.  Comparative in vitro activities of linezolid, telithromycin, clarithromycin, levofloxacin, moxifloxacin, and four conventional antimycobacterial drugs against Mycobacterium kansasii.

Authors:  Fernando Alcaide; Laura Calatayud; Miguel Santín; Rogelio Martín
Journal:  Antimicrob Agents Chemother       Date:  2004-12       Impact factor: 5.191

5.  Rapid Identification of Mycobacterium tuberculosis and nontuberculous mycobacteria by multiplex, real-time PCR.

Authors:  E T Richardson; D Samson; N Banaei
Journal:  J Clin Microbiol       Date:  2009-03-18       Impact factor: 5.948

6.  Activation of an NLRP3 inflammasome restricts Mycobacterium kansasii infection.

Authors:  Chang-Chieh Chen; Sheng-Hui Tsai; Chia-Chen Lu; Shiau-Ting Hu; Ting-Shu Wu; Tsung-Teng Huang; Najwane Saïd-Sadier; David M Ojcius; Hsin-Chih Lai
Journal:  PLoS One       Date:  2012-04-30       Impact factor: 3.240

7.  Pulmonary Mycobacterium kansasii Infection Mimicking Malignancy on the (18)F-FDG PET Scan in a Patient Receiving Etanercept: A Case Report and Literature Review.

Authors:  Zaw Min; Mohan Amlani
Journal:  Case Rep Pulmonol       Date:  2014-10-20

8.  Chronic Tenosynovitis due to Mycobacteria kansasii in an Immunocompetent Host.

Authors:  Michael S Wang; Michael Berry; Alissa Lehto-Hoffman; Linh Vi; Nina Ramessar
Journal:  Case Rep Infect Dis       Date:  2018-04-16

9.  Mycobacterium Kansasii Infection and Microscopic Polyangiitis: An Unexpected Association.

Authors:  Ammar Alnaser; Konstantinos Parperis
Journal:  Cureus       Date:  2018-06-18

10.  Ethambutol-resistant Mycobacterium kansasii cervical lymphadenitis in an immunocompetent adult patient: A case report and literature review.

Authors:  Víctor Asensi; Juan J Palacios; Maria Rivas-Carmenado; Tomás Suárez-Zarracina; Enrique Garcia-Carus; Luis M Fernández; Héctor E Torres; Joshua Fierer; José A Carton
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2019-12-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.